Concurrent Chemoradiation for Mediastinal Oligometastases From Cervical Cancer: A Potentially Curative Treatment

被引：2

作者：

Bonilla, Carlos E. ^{[1
]}

Laguado, Martin Zapata ^{[2
]}

Quintero, Heliberto Paez ^{[3
]}

机构：

[1] Inst Nacl Cancerol, Oncol, Bogota, Colombia

[2] Univ Bosque, Clin Oncol, Bogota, Colombia

[3] Univ Ind Santander, Internal Med, Fdn Avanzar Fos, Bucaramanga, Colombia

来源：

CUREUS JOURNAL OF MEDICAL SCIENCE | 2020年 / 12卷 / 09期

关键词：

cervical; cancer; chemotherapy; oligometastatic; complete; mediastinal; curative; RADIATION-THERAPY; UTERINE CERVIX; PHASE-III; CARCINOMA; CISPLATIN; RECURRENT;

D O I：

10.7759/cureus.10596

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Currently, the standard treatment for women with metastatic cervical cancer is palliative chemotherapy with or without bevacizumab. Patients with oligometastatic disease seem to have a better prognosis than those with disseminated disease. We present two cases of women with mediastinal oligometastatic disease from cervical cancer treated with mediastinal radiotherapy concurrent with intravenous cisplatin. Both patients achieved a complete response that remained after a follow-up of more than three years.

引用

页数：6

共 18 条

[1]

Ali Nasir, 2017, BMJ Case Rep, V2017, DOI 10.1136/bcr-2017-221153

[2]

Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI [10.3322/caac.21609, 10.3322/caac.21492]

[3]

Global Cancer Observatory, 2018, CERV UT

[4] Stereotactic body radiation therapy for oligometastatic pulmonary tumors from cervical cancer [J].